Internal Medicine, Endocrinology, Diabetes, & Metabolism · Williamsville, NY
NPI
1396976403
Since 2009
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
115 Flint Rd, Diabetes Endocrinology Center of Wny
Williamsville, NY, 14221
Phone (716) 626-7970
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
593 services
Medicare patients, 2024
233
Average age 68
Drug cost, 2024
$3.5M
7,386 prescriptions
Company payments, 2024
$124
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Manav Batra was code 99214 (office e&m - established), 295 times for 185 patients. In total Manav Batra billed 593 services in 18 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 295 | 185 | $69.70 | $21K |
| 95251 Test - Miscellaneous | Office | 117 | 59 | $25.83 | $3,022 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 32 | 32 | $12.91 | $413 |
| 99443 Telephone Services | Office | 30 | 27 | $89.59 | $2,688 |
| 99204 Office E&M - New | Office | 19 | 19 | $83.50 | $1,586 |
| 99213 Office E&M - Established | Office | 18 | 14 | $50.14 | $903 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $98.48 | $1,083 |
By year: 2022 $41K for 682 services; 2023 $38K for 639 services; 2024 $35K for 593 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 29 | 24 | $3.85 | $112 |
| 83036 Blood Count | 15 | 14 | $9.52 | $143 |
Medicare prescription drug claims, 2024
In 2024, the drug Manav Batra prescribed most often to Medicare patients was Ozempic (Semaglutide), with 674 prescriptions and refills. In total Manav Batra wrote 7,386 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 674 | 1,042 | 153 | $971K |
| Levothyroxine Sodium Generic | 589 | 1,261 | 147 | $9,012 |
| Metformin Hcl Generic | 443 | 896 | 102 | $5,279 |
| Mounjaro Tirzepatide | 393 | 471 | 68 | $481K |
| Atorvastatin Calcium Generic | 376 | 812 | 100 | $4,860 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 348 | 930 | 129 | $59K |
| Trulicity Dulaglutide | 339 | 489 | 80 | $467K |
| Pioglitazone Hcl Generic | 243 | 538 | 61 | $2,989 |
| Jardiance Empagliflozin | 227 | 420 | 53 | $234K |
| Humalog Kwikpen U-100 Insulin Lispro | 220 | 512 | 97 | $75K |
| Glipizide Generic | 218 | 443 | 54 | $2,300 |
| Metformin Hcl Er Metformin Hcl | 193 | 462 | 56 | $3,097 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 161 | 353 | 74 | $21K |
| Novolog Flexpen Insulin Aspart | 109 | 222 | 45 | $29K |
| Methimazole Generic | 104 | 274 | 33 | $1,529 |
Brand drugs: 3,524 claims; generic drugs: 3,247 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Manav Batra $124 ($124 in general payments such as food, travel and fees) from 2 companies. The largest payer was Medtronic, Inc. with $106.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 1 | $106 |
| Ascensia Diabetes Care Us Inc. | 1 | $18.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.